Matthew has over 20 years clinical & commercial experience in the medical imaging & healthcare industries with significant expertise in Nuclear Medicine and PET/CT operations throughout Australia & Europe.
Beyond his clinical background in Nuclear Medicine, Matthew holds significant commercial experience in the broader pharmaceutical industry and has held multiple advisory roles in successful Radiology startups. His role as National Sales Manager with GMS combines a strong clinical and research background with an astute commercial acumen and deep understanding of the broader medical imaging sector. More recently, Matthew has played a key role in developing agile strategies around the upscaled development of theranostic tracers in both domestic and APAC markets.
Radiopharmaceutical Market Analysis & Commercialisation
Matthew’s experience in the management of clinical imaging budgets has been integral to the successful development and implementation of large-scale commercial strategies across multiple TGA/GMP licensed manufacturing facilities and radiopharmacies. Matthew has overseen upscaled commercialisation of several novel radiopharmaceuticals in regional markets and worked on optimising production efficiencies in both traditional and emerging molecular imaging markets related to theranostics.